4//SEC Filing
Fontenot Jason D. 4
Accession 0001209191-22-025811
CIK 0001001233other
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 5:09 PM ET
Size
6.3 KB
Accession
0001209191-22-025811
Insider Transaction Report
Form 4
Fontenot Jason D.
SVP, Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2022-04-25$4.83/sh−826$3,990→ 103,167 total
Footnotes (3)
- [F1]Represents shares underlying the portion of a restricted stock unit ("RSU") grant that vested on April 25, 2022 which were surrendered by the Reporting Person to the Issuer for tax withholding using the Issuer's closing stock price on April 25, 2022 of $4.83/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP").
- [F2]Includes: (a) 2,508 shares resulting from the April 25, 2022 final annual vesting installment of the Reporting Person's April 25, 2019 RSU grant, (b) 8,335 shares subject to the Reporting Person's February 25, 2020 RSU grant that will vest in one final annual installment on February 25, 2023, (c) 14,667 shares subject to the Reporting Person's February 25, 2021 RSU grant that will vest in two remaining annual installments of 7,333 shares and 7,334 shares on February 25, 2023 and 2024, respectively, and (continued in footnote 3)
- [F3](d) 45,100 shares subject to the Reporting Person's February 25, 2022 RSU grant that will vest as to one-quarter (1/4) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.
Documents
Issuer
SANGAMO THERAPEUTICS, INC
CIK 0001001233
Entity typeother
Related Parties
1- filerCIK 0001851761
Filing Metadata
- Form type
- 4
- Filed
- Apr 26, 8:00 PM ET
- Accepted
- Apr 27, 5:09 PM ET
- Size
- 6.3 KB